In early trading on Monday, shares of $Vertex Pharmaceuticals (VRTX)$ topped the list of the day's best performing components of the Nasdaq 100 index, trading up 3.0%. Year to date, Vertex Pharmaceuticals registers a 40.8% gain.$Vertex Pharmaceuticals(VRTX)$ had its price target boosted by stock analysts at JPMorgan Chase & Co.from $319.00 to $327.00 in a research note issued to investors on Monday,The Flyreports. JPMorgan Chase & Co.'s price target suggests a potential upside of 10.53% from the company's previous close. Vertex Shares Higher On Optimism About CRISPR Partnership A number of other equities analysts have also weighed in on $(VRTX)$
Can US Stocks Rest Easy With This Rally?
With the start of the Q3 earnings season, the market had a rare two-day rally. Investors start to expect this rally to be sustained. Every post above 50 characters will get 50 coins~ High quality post may get extra 50-200 coins~ Join our topic and express your opinions!